Ingabe lokhu okuvamile okuphuza isithako kungaba nemiphumela emihle yempilo?
I-taurine i-amino acid etholakala emzimbeni, ikakhulukazi enhliziyweni, ebuchosheni, amehlo kanye nemisipha. Nakuba imizimba yethu ingenza i-taurine, imithombo yokudla eyinhloko yinyama, inhlanzi, kanye nobisi. Ifomu le-taurine elenziwe ngokuyisisekelo iyisithako esiyisisekelo ekufakeni izithako neziphuzo zamandla ezifana ne-Red Bull.
Nakuba amazinga aphansi e-taurine aye ahlanganiswa nezimo eziningana (kufaka phakathi izifo zamehlo nezinkinga zenhliziyo), ucwaningo ngezinzuzo ze-supplement taurine lilinganiselwe.
Abagqugquzeli bathi i-taurine ingathuthukisa umsebenzi wokuqonda, ukuthuthukisa ukusebenza kwezemidlalo, ukugcina amehlo, ukuthuthukisa impilo yenhliziyo, ukulawula ushukela wegazi nokukhulisa amazinga wamandla. I-Taurine iyaziwa nangokuthi iyasebenza njenge-antioxidant.
Imiphumela Yempilo
Nakhu ukubuka ezinye izihluthulelo ezisemqoka kusukela ocwaningweni olutholakalayo ngemiphumela yezempilo ye-taurine:
1) Izifo Zenhliziyo
Ucwaningo lokuqala luveza ukuthi i-taurine ingasiza ukulwa nesifo senhliziyo, ngokusho kokubuyekezwa kocwaningo oluvela ku- Experimental and Clinical Cardiology . Abalobi be-review baqaphele ukuthi u-taurine anganikeza izinzuzo eziningana zomzimba (njengokuvikela ukuqina komzimba), kodwa qaphelisa ukuthi ucwaningo olwengeziwe luyadingeka ngaphambi kokugcwaliswa kwe-taurine kunganconywa ukuvimbela noma ukwelashwa kwanoma yisiphi isimo senhliziyo.
Kwesinye isifundo, ososayensi bathola ukuthi izithako ze-taurine zingasiza ukunciphisa ama-homocysteine (i-amino acid ekhonjiswe ekukhuliseni isifo senhliziyo lapho kutholakala emazingeni aphezulu).
Ishicilelwe ku- Advances in Medicine Experimental and Biology ngo-2009, lolu cwaningo lwabandakanya abesifazane abangu-22 abanempilo eneminyaka ephakathi. Ngemuva kwamasonto amane ukuthatha amagremu ama-3 e-taurine efomini lokugcwalisa nsuku zonke, abahlanganyeli bezocwaningo babonisa ukwehla okukhulu emazingeni e-homocysteine.
2) Ukucindezelwa Kwegazi Eliphakeme
I-Taurine ingasiza ekuphatheni ukucindezelwa kwegazi eliphezulu, ngokusho kocwaningo luka-2016 olwanyatheliswa ku- Hypertension .
Ukuze kuhlolwe, abantu abanesandulela-ngculazi bathola i-taurine supplementation noma i-placebo yamaviki angu-12. I-Taurine supplementation yanciphisa umfutho wegazi, ikakhulukazi kulabo abanegazi eliphakeme elivamile.
I-Taurine Ezingxenyeni Zamandla
I-Taurine iyisithako esivamile kwiziphuzo zamandla kagesi. Nakuba ezinye izifundo zokuqala zibonisa ukuthi i-taurine ingathuthukisa ukusebenza kwengqondo nokwandisa ukukhuthazela kokuzivocavoca, ucwaningo jikelele emiphumeleni yokuthuthukisa amandla ka-taurine inqunyelwe. Ngaphezu kwalokho, umbiko wezi-2010 oshicilelwe ku- The Physician and Sportsmedicine uthi imiphumela yokukhathala yeziphuzo zamandla kakhulu kungenzeka ngenxa yokuqukethwe kwe-caffeine (kunokuba okuqukethwe kwe-taurine).
Imithombo ye-Taurine
Okokuqala ngaphandle kwenkomo bile, igama elithi taurine lisuselwa egameni lesiLatin lenkomo noma inkunzi, "taurus". Naphezu kwemfundiso yamanga yokuthi i-taurine isuselwa kumduna wenkomo, uhlobo lwe-taurine ezinxilweni kanye ne-supplements amaningi yifomu yokwenza (eyenziwa ebhokisatri).
Imiphumela Ezingenakwenzeka
I-Taurine ingabangela ezinye imiphumela emibi (kubandakanya ukucheka, ukuhlukumeza, ukukhanda ikhanda, nokuzondwa).
Kube khona imibiko eminingi yamacala emibi ehlobene nokusetshenziswa kweziphuzo zamandla eziqukethe i-taurine, njengokungqubuzana nemiphumela yomsindo.
Embikweni wesigameko, indoda eneminyaka engu-19 ubudala yakha isimo sesikhumba esaziwa ngokuthi i-erythema multiform. Isiphuzo esine-taurine kwakukholelwa ukuthi yimbangela.
Uma ubona noma yimiphi imiphumela emibi ngenkathi uthatha izithako ze-taurine, kubalulekile ukuyeka ukusetshenziswa kwakho kwe-taurine.
Izindleko azange zihlolwe ukuphepha futhi ngenxa yokuthi izithako zokudla ngokuvamile azihambisani nomthetho, okuqukethwe kwemikhiqizo ethile kungase kuhluke kulokho okushiwo kwilebula lomkhiqizo.
Futhi khumbula ukuthi ukuphepha kwezidakamizwa kwabesifazane abakhulelwe, omama abahlengikazi, izingane, nalabo abanezimo zezokwelapha noma abaphuza imishanguzo ayisungulwa.
Ungathola amathiphu ekusebenziseni izithako lapha.
I-Takeaway
Nakuba u-taurine angase anikele ngemiphumela emihle yempilo, ukuzitholela ngokweqile inkinga yezempilo ekhona nge-supplementary taurine nokugwema ukunakekelwa okwenziwe udokotela kungaba nemiphumela emibi kakhulu. Uma ucabangela ukusetshenziswa kwezidakamizwa ze-taurine ngesimo esingapheli, buza udokotela wakho ukuze anqume isilinganiso esiphephile nesisebenzayo.
Imithombo:
> Ahn CS. Umphumela we-taurine supplementation kumazinga e-plasma homocysteine yabesifazane baseKorea abaneminyaka ephakathi. I-Adv Exp Med Biol. 2009; 643: 415-22.
> Kong WX, Chen SW, Li YL, Zhang YJ, Wang R, Min L, Mi X. Imiphumela ye-taurine ekuziphatheni kwezilinganiso ezinhlobonhlobo ezintathu zokukhathazeka. I-Pharmacol i-Biochem Behav. 2006 Feb; 83 (2): 271-6.
> Miyazaki T, Matsuzaki Y, Ikegami T, Miyakawa S, Doy M, Tanaka N, Bouscarel B. Umthamo womlomo osebenza kahle futhi osebenza kahle we-taurine ukuze usebenzise isikhathi eside ekusebenzeni kancani. Amino Acids. 2004 Dec; 27 (3-4): 291-8.
> Sun Q, Wang B, Li Y, et al. I-Taurine Supplementation Yinciphisa Ukucindezelwa Kwegazi Futhi Ithuthukisa Umsebenzi Wase-Vascular in Prehypertension: Okungahleliwe, Okubili Kokuphulukisa, Isifundo Esilawulwa Ngendawo. I-hypertension. 2016 Mar; 67 (3): 541-9.
> Xu YJ, Arneja AS, Tappia PS, NS Dhalla. Izinzuzo zezempilo ezingase zibe khona ze-taurine ezinesifo senhliziyo. I-Exp Clin Cardiol. Uhlobo lwe-2008; 13 (2): 57-65.
> Ukuziphendulela: Ulwazi oluqukethwe kule sayithi luhloswe ngezinjongo zemfundo kuphela futhi aluthathi iseluleko, ukuxilongwa noma ukwelashwa ngudokotela ovunyelwe. Akuhloselwe ukumboza zonke izinyathelo zokuqapha, ukusebenzisana kwezidakamizwa, izimo noma imiphumela emibi. Kufanele ufune ukunakekelwa okusheshayo kwezokwelapha kunoma yiziphi izinkinga zezempilo bese uthintana nodokotela wakho ngaphambi kokusebenzisa enye imithi noma wenze ushintsho ohlelweni lwakho.